FOGHORN THERAPEUTICS INC. - COMMON STOCK
4.4300
16-5月-25 13:45:00
15 分の遅延
株式
+0.1200
+2.78%
本日の幅
4.2650 - 4.4900
ISIN
N/A
ソース
NASDAQ
-
Foghorn Therapeutics Announces First Patient Dosed in First-in-Human Clinical Trial of FHD-609
23 8 2021 04:00:00 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Second Quarter 2021 Corporate Update
10 8 2021 04:00:02 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference
03 8 2021 05:30:00 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
09 7 2021 05:36:31 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Host Research & Development Day Webinar on June 15th
08 6 2021 04:00:01 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Present in Two Upcoming Investor Conferences
26 5 2021 05:00:03 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Program of FHD-286
17 5 2021 04:00:01 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Corporate Update
11 5 2021 04:00:02 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Appoints Ian Smith to its Board of Directors
28 4 2021 04:00:00 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics Provides Corporate Update
18 3 2021 05:00:00 提供 Nasdaq GlobeNewswire
-
UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
11 3 2021 14:11:35 提供 Nasdaq GlobeNewswire
-
Foghorn Therapeutics to Present Poster and Chair a Panel and at the AACR Annual Meeting 2021
11 3 2021 13:01:00 提供 Nasdaq GlobeNewswire